ELOVL1 Antikörper (AA 82-175) (FITC)
-
- Target Alle ELOVL1 Antikörper anzeigen
- ELOVL1 (ELOVL Fatty Acid Elongase 1 (ELOVL1))
-
Bindungsspezifität
- AA 82-175
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ELOVL1 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Elongation of very long chain fatty acids protein 1 protein (82-175AA)
- Isotyp
- IgG
- Top Product
- Discover our top product ELOVL1 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- ELOVL1 (ELOVL Fatty Acid Elongase 1 (ELOVL1))
- Andere Bezeichnung
- ELOVL1 (ELOVL1 Produkte)
- Synonyme
- AA407424 antikoerper, BB151133 antikoerper, Ssc1 antikoerper, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 antikoerper, ELOVL fatty acid elongase 1 antikoerper, Elovl1 antikoerper, ELOVL1 antikoerper
- Hintergrund
-
Background: Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Condensing enzyme that exhibits activity toward saturated C18 to C26 acyl-CoA substrates, with the highest activity towards C22:0 acyl-CoA. May participate to the production of both saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. Important for saturated C24:0 and monounsaturated C24:1 sphingolipid synthesis. Indirectly inhibits RPE65 via production of VLCFAs.
Aliases: 3 keto acyl CoA synthase ELOVL1 antibody, 3-keto acyl-CoA synthase ELOVL1 antibody, CGI 88 antibody, Elongation of very long chain fatty acids (FEN1/Elo2 SUR4/Elo3 yeast) like 1 antibody, Elongation of very long chain fatty acids like 1 antibody, Elongation of very long chain fatty acids protein 1 antibody, ELOV1_HUMAN antibody, ELOVL 1 antibody, ELOVL FA elongase 1 antibody, ELOVL fatty acid elongase 1 antibody, ELOVL1 antibody, Ssc1 antibody, Ssc1, mouse, homolog of antibody, very long chain 3 oxoacyl CoA synthase 1 antibody, Very-long-chain 3-oxoacyl-CoA synthase 1 antibody
- UniProt
- Q9BW60
-